Gene Synthesis Market TOC | Table of Content

The report covers Gene Synthesis Market Trends and Segments such as method including Solid-phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis. Services comprise Antibody DNA Synthesis, Viral DNA Synthesis and other services. Applications span Gene & Cell Therapy Development, Vaccine Development and Disease Diagnosis. Other miscellaneous applications also contribute to the market’s diversity. The report offers the value (in USD Billion) for the above segments.

Overview of the Global Gene Synthesis Market

The global gene synthesis market, valued at approximately US$ 2.1 billion in 2023, is anticipated to reach around US$ 9.38 billion by 2033, growing at a compound annual growth rate (CAGR) of 16.14% from 2024 to 2033. This growth is driven by the increasing demand for gene therapy and personalized treatments.

Gene synthesis is a reliable and cost-effective method that ensures 100% sequence accuracy in custom DNA constructs. As a powerful tool in molecular biology, DNA synthesis has transformed modern biological research and is becoming an integral part of research workflows. The market has expanded significantly due to the diverse applications of synthetic biology.

A growing number of universities, research institutions, and small biotech startups are outsourcing gene synthesis services to specialized companies. The market has attracted substantial governmental and private investments, with significant funding directed towards developing gene synthesis infrastructure and technologies. These investments and research grants have facilitated the introduction of new products and technological advancements, further fueling the growth of the gene synthesis market.

Gene Synthesis Market TOC | Table of Content

Executive Summary

• Market Overview
• Key Findings
• Market Trends
• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Competitive Landscape
• Company Profiles
• Market Size and Forecast

Introduction

• Research Methodology
• Assumptions and Acronyms Used
• Market Definition and Scope

Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Market Challenges
• Porter’s Five Forces Analysis

Market Size and Forecast

• Global Market Size and Forecast (by Value and Volume)
• Regional Market Size and Forecast (by Value and Volume)
• Market Size and Forecast by Segmentation (by Value and Volume)

Market Segmentation

By Method (Value and Volume)

• Solid-phase Synthesis
  • Cross-sectional Analysis:
    • Resins Used
    • Automation Levels
• Chip-based Synthesis
  • Cross-sectional Analysis:
    • Microarray Technology
    • Throughput Rates
• PCR-based Enzyme Synthesis
  • Cross-sectional Analysis:
    • Amplification Efficiency
    • Multiplexing Capability

By Services (Value and Volume)

• Antibody DNA Synthesis
  • Cross-sectional Analysis:
    • Monoclonal Antibodies
    • Polyclonal Antibodies
• Viral DNA Synthesis
  • Cross-sectional Analysis:
    • Virus Types (e.g., Retroviruses, Adenoviruses)
    • Vector Design
• Others
  • Cross-sectional Analysis:
    • RNA Synthesis
    • Specialty Oligonucleotides

By Application (Value and Volume) 

• Gene & Cell Therapy Development
  • Cross-sectional Analysis:
    • Gene Editing Technologies (e.g., CRISPR-Cas9)
    • Cell Types (e.g., Stem Cells, T Cells)
• Vaccine Development
  • Cross-sectional Analysis:
    • Antigen Selection
    • Adjuvant Formulation
• Disease Diagnosis
  • Cross-sectional Analysis:
    • Biomarker Identification
    • Diagnostic Assay Development
• Others
  • Cross-sectional Analysis:
    • Synthetic Biology Applications
    • Agricultural Biotechnology

By Region (Value and Volume) 

• North America
  • U.S.
    • Cross-sectional Analysis:
      • Regulatory Environment
      • Biotech Clusters
  • Canada
    • Cross-sectional Analysis:
      • Healthcare Infrastructure
      • Research Funding
• Europe
  • U.K.
    • Cross-sectional Analysis:
      • Brexit Impact
      • NHS Integration
  • Germany
    • Cross-sectional Analysis:
      • Bioeconomy Initiatives
      • Industry Associations
  • France
    • Cross-sectional Analysis:
      • Biomedical Research Centers
      • Regulatory Landscape
  • Rest of Europe
    • Cross-sectional Analysis:
      • Emerging Markets
      • Regulatory Harmonization
• Asia-Pacific
  • China
    • Cross-sectional Analysis:
      • Biotech Regulations
      • Market Entry Strategies
  • Japan
    • Cross-sectional Analysis:
      • Aging Population Impact
      • Advanced Research Facilities
  • India
    • Cross-sectional Analysis:
      • Biotech Startup Ecosystem
      • Government Initiatives
  • Rest of Asia-Pacific
    • Cross-sectional Analysis:
      • Healthcare Expenditure
      • Market Access Challenges
• Latin America
  • Brazil
    • Cross-sectional Analysis:
      • Bioinformatics Capabilities
      • Pharmaceutical Industry Growth
  • Mexico
    • Cross-sectional Analysis:
      • Healthcare Reforms
      • Economic Factors
  • Rest of Latin America
    • Cross-sectional Analysis:
      • Regulatory Developments
      • Market Penetration Strategies
• Middle East and Africa (MEA)
  • GCC
    • Cross-sectional Analysis:
      • Healthcare Infrastructure Investment
      • Economic Diversification
  • South Africa
    • Cross-sectional Analysis:
      • Disease Burden
      • Research Facilities
  • Rest of MEA
    • Cross-sectional Analysis:
      • Political Stability
      • Market Entry Barriers

Competitive Landscape

• Market Share Analysis
• Competitive Strategies
• Company Profiles
  • Boster Biological Technology
    • Company Overview
    • Financial Performance
    • Product Portfolio
    • Business Strategy
    • Recent Developments
  • OriGene Technologies, Inc.
  • Integrated DNA Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • ProMab Biotechnologies, Inc.
  • Biomatik
  • ProteoGenix, Inc.
  • Twist Bioscience
  • Brooks Automation, Inc. (GENEWIZ)
  • GenScript

Emerging Trends

• Technological Advancements
• New Product Launches
• Strategic Alliances and Partnerships
• Regulatory Landscape

Investment Analysis

• Market Investment Scenario
• Investment Opportunities
• Funding and Investments

Appendix

• List of Abbreviations
• References
• Research Methodology
• Disclaimer

Conclusion

• Key Takeaways
• Future Outlook

To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5170

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare